GTC's Solid Tumor profile plus provides clinically actionable data including: -CNV's -Amplifications -MSI/TMB -Viral HPV, EBV and TTV -HLA Genotyping -Gene expession -Fusions/translocations -Deletions/Duplications Exon skipping/Alternative splicing and more https://lnkd.in/d8NzX7b #RNA #DNA #Geneexpression
Genomic Testing Cooperative
Biotechnology Research
Lake Forest, California 2,807 followers
Making Genomics Available and Affordable for Everyone
Über uns
Our Mission is to create a diagnostic service that provides access to advanced genomic testing in communities everywhere. Our testing provides answers for ALL cancers covering both solid tumors and hematologic neoplasms. Genomic Testing Cooperative (GTC) is a different kind of cancer diagnostic laboratory. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. In creating a network of Co-Op partners, we help get results to physicians faster, share knowledge and generate better outcomes for patients.
- Website
-
https://genomictestingcooperative.com
External link for Genomic Testing Cooperative
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Lake Forest, California
- Typ
- In Privatbesitz
- Gegründet
- 2018
- Spezialitäten
- Genomic testing, Precision Medicine, Next Gen Sequencing, Oncology, Hematology, Comprehensive Genomic Profiling, Leukemia, Lymphoma, Myeloma, Lung Cancer, Breast Cancer, Colon Cancer, and CDx
Standorte
-
Primäre
Wegbeschreibung erhalten
25371 Commercentre Dr
Lake Forest, California 92630, US
Employees at Genomic Testing Cooperative
-
Jeffrey Owen
Vice President, Marketing @ Genomic Testing Cooperative
-
Rachel Rosenberger
Lead Clinical Data Reporter at Genomic Testing Cooperative
-
Maher Albitar
Founder, Chief Executive Officer and Chief Medical Officer at Genomic Testing Cooperative
-
Jennifer Varca
Vice President, Business Development
Aktualisierungen
-
GTC's Liquid Trace does more than liquid biopsies like: ▫ TMB ▫ HRR ▫ Known and novel fusions ▫ T and B-cell clonality ▫ HLA genotyping ▫ Viral RNA for EBV/HPV/TTV ▫ Gene expression ▫ Alternative splicing/exon skipping and more https://lnkd.in/eEUyiVEx #cfRNA #clonality #HPV
-
-
We're giving a talk on Transcriptomics and AI in transforming precision diagnosis presented by Dr. Maher Albitar CEO/CMO of GTC Nov 2 at 11:40-12:35 Panelist to be announced soon. Learn more: https://lnkd.in/gBM424UK #Precisionmedicine #RNA #cfRNA
-
-
Hematology Profile Plus and Liquid Trace Hematology - A Better Way to Evaluate and Classify Patients with Multiple Myeloma Test on fresh bone marrow, peripheral blood or FFPE Enrichment of CD138+ plasma cells Identify relevant CNVs, even on FFPE specimens RNA sequencing allows identification of fusions and gene overexpression of important myeloma prognostic factors including CCND1, MAF, MAFB, MYC, and NSD2 Determine the clonotype for use in monitoring Significant possible germline mutations are also reported Monitor treatment response with Liquid Trace and more Learn more: https://lnkd.in/dWGyJYW6 #cfRNA #multiplemyeloma #CD138
-
-
AI helps subtype lymphoma by: o Determine DLBCL cell of origin, GCB vs ABC, using gene expression profiling o Detect follicular lymphoma in transformation to DLBCL o Distinguish subtypes of small B-cell lymphomas o Distinguish subtypes of T-cell lymphoma, such as AITL from PTCL o Assists in lymphoma subtyping, which can be challenging by routine pathology, especially when tissue is limited Learn more: https://lnkd.in/g_Biiba
-
-
Use Liquid Trace to identify co-existing tumors like lymphoma, myeloid neoplasms or CHIP. Learn more: https://lnkd.in/dWGyJYW6 #Lymphoma #Myeloma #lymphoid neoplasms
-
-
Liquid Trace's cfDNA and cfRNA delivers comprehensive results. Check out some of our sample reports and see what's possible. Learn more: https://lnkd.in/duiFUP8F #CSF #cfRNA #cfDNA
-
-
One of the unique features of GTC's Liquid Trace assay is that it can be highly sensitive when a tissue biopsy for baseline testing isn't available and still offer the broad coverage benefits of comprehensive genomic profiling. https://lnkd.in/eEUyiVEx #Tumorinformed #Tumoragnostic #cfRNA
-
-
GTC published an abstract at ASCO titled Multiple Alternative Splicing of HER2 transcripts and Exon Skipping with Potential Consequences on Function and Antibody-Based Therapy. Check out this abstract: https://lnkd.in/eEdFuHeV #Exonskipping #Alternativesplicing #RNA #ASCO
-
-
Don’t let QNS/TNP fears stop you from ordering comprehensive genomic profiling. Using innovative chemistry helps reduce QNS and TNP rates. GTC's QNS rate is currently less than 1%. Most labs using NGS are greater than >10% QNS/TNP Read more: https://lnkd.in/gBmGD6u #GenomicTestingCooperative #QNS #ComprehensiveGenomicProfiling #PrecisionMedicine #CancerDiagnosis
-